Log in or register
Share on LinkedInShare on LinkedIn

ARTICLE · 30 APRIL 2015

Changes To The Plant Breeders' Rights Act Have Arrived

Smart & Biggar
Explore more from Smart & Biggar

Canada’s Plant Breeders’ Rights Act (PBRA) has recently been amended in order to strengthen the protection of plant varieties in Canada and to bring the PBRA in line with international plant breeding standards.

CanadaReal Estate and Construction
Micheline Gravelle
Micheline Gravelle
Author LinkedIn connections

Canada's Plant Breeders' Rights Act (PBRA) has recently been amended in order to strengthen the protection of plant varieties in Canada and to bring the PBRA in line with international plant breeding standards. Significant amendments have been made to the nature and scope of plant breeders' rights, the term of protection, and the requirements for novelty.

The PBRA was amended in Bill-C-18 along with various other Acts related to agriculture, including the Feeds Act, the Seeds Act and the Plant Protection Act. This omnibus bill, entitled the Agriculture Growth Act, received Royal Assent February 25, 2015. The amended provisions of the PBRA came into force by an Order in Council dated February 27, 2015.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

Related Comparative Guides

See more popular content from

Article

Could The Old Ontario Construction Lien Act Still Apply To Your Project? The Court Of Appeal Weighs In

A 2026 Ontario Court of Appeal decision reveals that construction contracts signed years after legislative reforms may still be governed by the old Construction Lien Act if the procurement process began before July 1, 2018. The ruling demonstrates how early project proposals and negotiations can determine which statutory regime applies, regardless of when the final contract was executed or where the project was ultimately built.
CanadaReal Estate and Construction
Miller Thomson
Miller Thomson
Article

Here’s The Drill: Introducing The New CCDC 32 – 2026 Progressive Design-Build Contract

CCDC 32 introduces a progressive design-build framework that allows owners and design-builders to collaboratively develop project scope, budget, and schedule before committing to a final price. Through a two-phase structure with project gates and off-ramp provisions, this standardized contract addresses complex construction projects where requirements cannot be fully defined at the outset. How does this collaborative approach balance flexibility with cost certainty while reshaping traditional roles in const
CanadaReal Estate and Construction
WeirFoulds LLP
WeirFoulds LLP
Article

Project Owner’s Duty Of Good Faith: Court Of Appeal Upholds $15.7 Million Award To Contractor

La Cour d'appel du Québec confirme une indemnité de 15,7 M$ contre un donneur d'ouvrage pour manquement à son devoir de bonne foi dans l'affaire PG4 c. Énergir. L'arrêt établit qu'un donneur d'ouvrage ne peut créer des attentes légitimes quant au traitement d'une réclamation pour ensuite se réfugier derrière le formalisme contractuel, consacrant ainsi les principes de loyauté et de cohérence dans les contrats de construction.
CanadaReal Estate and Construction
Borden Ladner Gervais LLP
Borden Ladner Gervais LLP
Article

Health Canada Updates Policies On Foreign Regulatory Actions, Summary Reporting, Compliance & Enforcement And Requests For New Data

Health Canada issued revised guidance on notifying Health Canada of foreign actions, effective October 1, 2026. The revised guidance clarifies the requirements to notify Health Canada of certain foreign regulatory actions specified in subsection C.01.050(2) of the Food and Drug Regulations in the specified foreign jurisdictions, which involve a serious risk of injury to human health and are relevant to the safety of the drug.
CanadaFood, Drugs, Healthcare, Life Sciences
Smart & Biggar
Smart & Biggar
Article

Pharmaceutical And Life Sciences Sector Task Force Submits Final Report To The Ministers Of Health And Industry

The Pharmaceutical and Life Sciences Sector Task Force has released its final report addressing Canada's challenges in medication access, regulatory processes, and life sciences competitiveness. The report examines structural issues including lengthy reimbursement pathways, underperforming clinical trial environments, and erosion of domestic investment, while proposing 39 recommendation areas to strengthen Canada's health sovereignty and industrial strategy.
CanadaFood, Drugs, Healthcare, Life Sciences
Smart & Biggar
Smart & Biggar
Article

A KTEP Ahead: Canada's New Mechanism For Advanced Examination Of Patent Applications

For a Canadian patent application to be examined, an applicant must file a request for examination with the Canadian Intellectual Property Office (CIPO). In most cases, the order in which applications are examined is based on the order that the requests for examination are received. An applicant may be able to accelerate examination of their patent application through several existing mechanisms, including advancing examination via special order, accelerating examination of applications related to green technology, and the Patent Prosecution Highway (PPH).
CanadaIntellectual Property
Smart & Biggar
Smart & Biggar